Day 1 Highlights - TCT 2019

2 years 9 Views


Dr. Peter Block and Dr. Spencer King discuss apixaban vs. warfarin and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndromes (AUGUSTUS ACS—2:22) and ticagrelor monotherapy vs. ticagrelor-plus-aspirin in high-risk percutaneous coronary intervention (TWILIGHT—0:26). Full coverage of TCT 2019 at